上腺素再吸收和抗抑郁药物阻塞的动态机制由膜潜力调节
Xiaoyu Zhao1, Feng Gao1,2,3
1Department of Physics, School of Science, Tianjin University, Tianjin 300072, China.
Journal of chemical theory and computation
|February 24, 2025
概括
膜潜能动态控制北上腺素载体 (NET) 功能,影响神经递质的再吸收. 这项研究揭示了电压如何影响NET.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 计算化学的计算化学
背景情况:
- 上腺素运输体 (NET) 调节神经递质恒常,对神经信号传递至关重要.
- 膜潜力的对NET功能和北上腺素 (NE) 运输的影响仍然不太清楚.
- 了解NE运输和抗抑郁药阻断机制对于神经科学至关重要.
研究的目的:
- 通过NET阐明NE运输的动态分子机制.
- 研究膜电位对NET功能和NE再吸收的影响.
- 分析抗抑郁药对NET的电压依赖性阻塞效应.
主要方法:
- 对NET-NE/抗抑郁药系统的计算分析.
- 检查结构性,静电性和动态性特性.
- 在不同的膜电位下,研究基质运输通路和结合相互作用.
主要成果:
- NET 函数表现出动态电压依赖性,超极化有利于 NE 回收.
- 膜潜力通过静电驱动路径显著改变NE运输.
- 抗抑郁药物通过占据结合途径来阻止NE的再吸收,具有电压依赖的结合亲和力.
结论:
- 膜潜力是NET介导的NE再吸收的关键调节器.
- 抗抑郁药对NET的阻断是电压依赖的,影响其有效性.
- 结合电场的计算策略可以揭示膜蛋白-连接体相互作用的关键机制.
相关概念视频
Drugs Affecting Neurotransmitter Release or Uptake
921
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
921
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
Neurochemical Transmission: Sites of Drug Action
2.0K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.0K
Antidepressant Drugs: MAOIs and Other Agents
178
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
178
Adrenergic Neurons: Neurotransmission
3.3K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
3.3K
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K


